Selective targeting of indel-inferred differences in spatial structures of highly homologous proteins

Proteins: Structure, Function and Genetics

Volumn 58, Issue 4, 2005, Pages 950-954

  Cherkasov, Artem ^a   Nandan, Devki ^a   Reiner, Neil E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Folds evolution; Protein insertions and deletions; Protein recognition, drug design

Indexed keywords

ELONGATION FACTOR 1ALPHA; VIRULENCE FACTOR;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CELL SURVIVAL; DRUG DESIGN; DRUG TARGETING; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; TECHNIQUE;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL LINE; COMPUTATIONAL BIOLOGY; DRUG DESIGN; EVOLUTION, MOLECULAR; GENE DELETION; HUMANS; IMMUNOPRECIPITATION; LEISHMANIA; LEISHMANIA DONOVANI; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MONOCYTES; PEPTIDE ELONGATION FACTOR 1; PEPTIDES; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; PROTEOMICS; SEQUENCE HOMOLOGY, AMINO ACID; SULFOLOBUS SOLFATARICUS;

EID: 13944253296     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.20391     Document Type: Article

References (23)

1. Qian B, Goldstain RA. Distribution of indel lengths. Proteins 2001;45:102-104.
2. Gu X, Li WH. The size distribution of insertions and deletions in human and rodent pseudogenes suggests the logarithmic gap penalty for sequence alignment. J Mol Evol 1995;40:464-473.
3. Fechteler F, Dengler U, Schomburg D. Prediction of protein three-dimensional structures in insertion and deletion regions: a procedure for searching data bases of representative protein fragments using geometric scoring criteria. J Mol Biol 1995;253: 114-131.
4. Wrable JO, Grishin N, Gaps in structurally similar proteins: towards improvement of multiple sequence alignment. Proteins 2003;54:71-87.
5. Pascarella S, Argos P, Analysis of insertions/deletions in protein structures. J Mol Biol 1992;224:461-471.
6. Benner SA, Cohen MA, Gonnet GH. Empirical and structural models for insertions and deletions in the divergent evolution of proteins. J Mol Biol 1993;229:1065-1082.
7. Ogata RT. Method for identifying peptides that affect protein-protein interactions and complement modulating peptides. International Patent WO 97/01578,16 January, 1997.
8. Nandan D, Lo R, Reiner NE. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signalling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun 1999;67:4055-4063.
9. Nandan D, Cherkasov A, Yi T, Reiner NE. Molecular cloning and characterization of elongation factor-1α from Leishmania donovani reveals structural and functional differences from host EF-1α. Biochem Biophys Res Commun 2003;302:646-562.
10. Oliver M., Romero-Gallo BJ, Matte C, Blanchette J, Posner BI, Tremblay MJ, Faure R. Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition: effect on: murine leishmaniasis progression. J Biol Chem 1998;273:13944-13949.
11. Blanchette J, Racette N, Faure R, Siminovitch KA, Oliver M. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur J Immun 1999;29:3737-3744.
12. Forget G, Siminovitch KA, Brochu SRS, Radzioch D, Oliver M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immun 2001;31:3185-3196.
13. Nandan D, Taolin Y., Lopez M., Lai C., Reiner NE. Leishmania EF1α activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J Biol Chem 2002;227:50190-50197.
14. Gutierrez Y, Maksem JA, Reiner NE. Pathologic changes in murine leishmaniasis (Leishmania donovani) with special reference to the dynamics of granuloma formation in the liver. Am J Pathol 1984;114:222-230.
15. Swiss-PDBviewer, Version 3.7. N. Guex. GlaxoSmithKline, 1995-2001.
16. Molecular Operational Environment (MOE), Version 2003.02. Montreal: Chemical Computation Group Inc.; 2003.
17. Halgren TA. Merck molecular force field: 1. Basis, form, scope, parameterization, and performance of MMFF94. J Comp Chem 1996;17:490-519.
18. Cuff JA, Clamp ME, Siddiqui AS, Finlay M, Barton GJ. JPred: a consensus secondary structure prediction server. Bioinformatics 1998;14:892-893.
19. Ouali M, King RD. Cascaded multiple classifiers for secondary structure prediction. Protein Sci 2000;9:1162-1176.
20. Pollastri G, Przybylski D, Rost B, Baldi P. Improving the prediction of protein secondary structure in three and eight classes using recurrent neural networks and profiles. Proteins 2002;47:228-235.
21. Sibanda BL, Thornton JM. Accommodating sequence changes in β-hairpins in proteins. J Mol Biol 1993;229:428-447.
22. Vitagliano L, Masullo M, Sica F, Zagari A, Bochhini V. The crystal structure of Sulfolobus solfataricus elongation factor 1α in complex with GDP reveals novel feature in nucleotide binding exchange. EMBO J 2001;20:5305-5311.
23. Andersen GR, Nissen P, Nyborg J. Elongation factors in protein biosynthesis. Trends Biochem Sci 2003;28:434-440.